JAMA Psychiatry · 2020 · 139 citations · 34 references
MedicineNeurologyNeuroscienceDementiaGerontologyProteomicsAlzheimer DiseaseCognitive AgingDementia BiomarkersDementia With Lewy BodiesNeurodegenerative DiseasesNeuropathology Of AgingAlzheimer Disease DementiaCognitive Decline PreventionCortical Lewy BodiesLongitudinal Cognitive DeclineMass Spectrometry ProteomicsResilienceTandem Mass SpectrometryTandem Mass Tag Quantification
Importance: Identifying genes and proteins for cognitive resilience (ie, targets that may be associated with slowing or preventing cognitive decline regardless of the presence, number, or combination of common neuropathologic conditions) provides a complementary approach to developing novel therapeutics for the treatment and prevention of Alzheimer disease and related dementias. Objective: To identify proteins associated with cognitive resilience via a proteome-wide association study of the human dorsolateral prefrontal cortex. Design, Setting, and Participants: This study used data from 391 community-dwelling older persons who participated in the Religious Orders Study and the Rush Memory and Aging Project. The Religious Orders Study began enrollment January 1, 1994, and the Rush Memory and Aging Project began enrollment September 1, 1997, and data were collected and analyzed through October 23, 2019. Exposures: Participants had undergone annual detailed clinical examinations, postmortem evaluations, and tandem mass tag proteomics analyses. Main Outcomes and Measures: The outcome of cognitive resilience was defined as a longitudinal change in cognition over time after controlling for common age-related neuropathologic indices, including Alzheimer disease, Lewy bodies, transactive response DNA-binding protein 43, hippocampal sclerosis, infarcts, and vessel diseases. More than 8000 high abundance proteins were quantified from frozen dorsolateral prefrontal cortex tissue using tandem mass tag and liquid chromatography-mass spectrometry. Results: There were 391 participants (273 women); their mean (SD) age was 79.7 (6.7) years at baseline and 89.2 (6.5) years at death. Eight cortical proteins were identified in association with cognitive resilience: a higher level of NRN1 (estimate, 0.140; SE, 0.024; P = 7.35 × 10-9), ACTN4 (estimate, 0.321; SE, 0.065; P = 9.94 × 10-7), EPHX4 (estimate, 0.198; SE, 0.042; P = 2.13 × 10-6), RPH3A (estimate, 0.148; SE, 0.031; P = 2.58 × 10-6), SGTB (estimate, 0.211; SE, 0.045; P = 3.28 × 10-6), CPLX1 (estimate, 0.136; SE, 0.029; P = 4.06 × 10-6), and SH3GL1 (estimate, 0.179; SE, 0.039; P = 4.21 × 10-6) and a lower level of UBA1 (estimate, -0.366; SE, 0.076; P = 1.43 × 10-6) were associated with greater resilience. Conclusions and Relevance: These protein signals may represent novel targets for the maintenance of cognition in old age.
34
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Julie A. Schneider, Zoe Arvanitakis, Sue E. Leurgans et al. · Annals of Neurology · 2009 · 931 citations · Full text
Medicine, Neurology, Neuroscience +17
Person‐specific contribution of neuropathologies to cognitive loss in old age
Patricia A. Boyle, Lei Yu, R. J. Wilson et al. · Annals of Neurology · 2017 · 516 citations
Medicine, Neurology, Neuroscience +17
Much of late life cognitive decline is not due to common neurodegenerative pathologies
Patricia A. Boyle, R. J. Wilson, Lei Yu et al. · Annals of Neurology · 2013 · 330 citations · Full text
Medicine, Neurology, Neuroscience +17
Neural reserve, neuronal density in the locus ceruleus, and cognitive decline
R. J. Wilson, Sukriti Nag, Patricia A. Boyle et al. · Neurology · 2013 · 291 citations · Full text
Medicine, Neurobiology, Neuroscience +15